|4Jan 7, 4:32 PM ET

Colgin Mark 4

4 · AspenBio Pharma, Inc. · Filed Jan 7, 2011

Insider Transaction Report

Form 4
Period: 2011-01-05
Colgin Mark
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2011-01-05+10,00010,000 total
    Exercise: $0.59Exp: 2021-01-05Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option to purchase 10,000 shares of common stock shall become exercisable as to 33.33% of the shares on each of January 5, 2012 and January 5, 2013, and as to the remaining 33.34% of the shares on January 5, 2014.

Documents

1 file
  • 4
    appy_colgin.xmlPrimary

    FORM 4